AstraZeneca warned of slowing China growth after it lost a major government procurement deal for Crestor to a generic drugmaker. BeiGene’s CEO nabbed a $ 15 million special equity award in 2018 and ranked as biopharma’s second-highest-paid exec for the year. China’s Kangmei Pharma saw shares plummet on news that its shares could be delisted after a $ 4.4 billion accounting “error.” 1.… Read More »
An additional 3,591 women have not received information about NHS cervical cancer screening, it has emerged. Capita, the company contracted to send out the screening invitations, made the discovery while investigating an administrative error already known to have affected 40,000 women in England. NHS England says there is no evidence of any harm having resulted… Read More »
NHS hit by fresh cancer screening blunder: Lives at risk as nearly 50,000 women are not sent smear test letters, reminders or test results by ‘shambolic’ private firm with a £330million Government contract More than 4,500 women were not sent the results of their screening tests Whereas more than 40,000 were not sent appointment invitations… Read More »